Telomeres and thyroid cancer

Current Genomics

Volumn 10, Issue 8, 2009, Pages 526-533

  Capezzone, Marco ^a   Marchisotta, Stefania ^a   Cantara, Silvia ^a   Pacini, Furio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

hTERT; Telomeres; Thyroid cancer

Indexed keywords

TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ASPIRATION BIOPSY; BENIGN TUMOR; CARCINOGENESIS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DNA DAMAGE; ENZYME REACTIVATION; FAMILIAL CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ACTIVITY; GENE EXPRESSION; GENETIC RISK; GOITER; GOLD STANDARD; HUMAN; IMMUNOHISTOCHEMISTRY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TELOMERE; THYROID ADENOMA; THYROID CANCER; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; TISSUE DISTRIBUTION;

EID: 73349141969     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920209789503897     Document Type: Review

References (65)

1. Davies, L.; Welch, H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA, 2006, 295, 2164-2167.
2. Leenhardt, L.; Bernier, M.O.; Boin-Pineau, M.H.; Conte Devolx, B.; Maréchaud, R.; Niccoli-Sire, P.; Nocaudie, M.; Orgiazzi, J.; Schlumberger, M.; Wémeau, J.L.; Chérie-Challine, L.; De Vathaire, F. Advances in diagnostic practices affect thyroid cancer incidence in France. Eur. J. Endocrinol., 2004, 150, 133- 139.
3. th ed. Paris: Editions Nucleon; 2003, pp. 3-317.
4. Fagin, J.A. How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy. J. Endocrinol., 2004, 183, 249-56.
5. Kebebew, E. Hereditary non-medullary thyroid cancer. World J. Surg., 2008, 32, 678-82.
6. Sturgeon, C.; Clark, O.H. Familial nonmedullary thyroid cancer. Thyroid, 2005, 15, 588-593.
7. Giardiello, F.M.; Offerhaus, G.J.A.; Lee, D.H.; Krush, A.J.; Tersmette, A.C.; Booker, S.V.; Kelley, N.C.; Hamilton, S.R. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut, 1993, 34, 1394-1396.
8. Liaw, D.; Marsh, D.J.; Li, J.; Dahia, P.L.M.; Wang, S.I.; Zheng, Z.; Bose, S.; Call, K.M.; Tsou, H.C.; Peacocke, M.; Eng, C.; Parsons, R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 1997, 16, 64-67.
9. Kelly, M.D.; Hugh, T.B.; Field, A.S.; Fitzsimons, R. Carcinoma of the thyroid gland and Gardner's syndrome. Aust. N Z J Surg., 1993, 63, 505-9.
10. Goto, M.; Miller, R.W.; Ishikawa, Y.; Sugano, H. Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol. Biomarkers Prev., 1996, 5, 239-246.
11. Stratakis, C.A.; Courcoutsakies, N.A.; Abati, A.; Filie, A.; Doppman, J.L.; Carney, A.; Shawker, T. Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney Complex). J. Clin. Endocrinol. Metab., 1997, 82, 2037-43.
12. Malchoff, C.D.; Sarfarazi, M.; Tendler, B.; Forouhar, F.; Whalen, G.; Joshi, V.; Arnold, A.; Malchoff, D.M. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J. Clin. Endocrinol. Metab., 2000, 85, 1758-1764.
13. Canzian, F.; Amati, P.; Harach, H.R.; Kraimps, J.L.; Lesueur, F.; Barbier, J.; Levillain, P.; Romeo,G.; Bonneau, D. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am. J. Human Genet., 1998, 63, 1743-1748.
14. McKay, J.D.; Lesueur, F.; Jonard, L.; Pastore, A.; Williamson, J.; Hoffman, L.; Burgess, J.; Duffield, A.; Papotti, M.; Stark, M.; Sobol, H.; Maes, B.; Murat, A.; Kaariainen, H.; Bertholon-Gregoire, M.; Zini, M.; Rossing, M.A.; Toubert, M.E.; Bonichon, F.; Cavarec, M.; Bernard, A.M.; Boneu, A.; Leprat, F.; Haas, O.; Lasset, C.; Schlumberger, M.; Canzian, F.; Goldgar, D.E.; Romeo, G. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am. J. Hum. Genet., 2001, 69, 440-446.
15. Charkes, N.D. On the prevalence of familial nonmedullary thyroid cancer. Thyroid, 2006, 8, 857-858.
16. Ju, Z.; Rudolph, L. Telomere dysfunction and stem cell ageing. Biochimie, 2008, 90, 24-32.
17. Gilson, E.; Londono-Vallejo, A. Telomere length profile in humans. Cell Cycle, 2007, 6, 1-9.
18. Artandi, S.E.; Alson, S.; Tietze, M.K.; Sharpless, N.E.; Ye, S.; Greenberg, R.A.; Castrillon, D.H.; Horner, W.J.; Weiler, S.R.; Carrasco, R.D.; DePinho, R.A. Constitutive telomerase expression promotes mammary carcinomas in aging mice. PNAS, 2002, 99, 8191-6.
19. Vulliamy, T.; Marrone, A.; Szydlo, R.; Walne, A.; Mason, P.J.; Dokal, I. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat. Genet., 2004, 36, 447-9.
20. Wu, X.; Amos, C.I.; Zhu,Y.; Zhao, H.; Grossman, B.H.; Shay, J.W.; Luo, S.; Ki Hong, W.; Spitz, M.R. Telomere dysfunction: a potential cancer predisposition factor. J. Nat. Cancer Inst., 2003, 95, 1211-18.
21. Graakjaer, J.; Der-Sarkissian, Schmitz, A.; Bayer, J.; Thomas, G.; Kolvraa, S.; Londono-Vallejo, A. Allele-specific relative telomere lengths are inherited. Human Genet., 2006, 119, 344-50.
22. Graakjaer, J.; Londono-Vallejo, J.A.; Christensen, K.; Kolvraa, S. The pattern of chromosome-specific variations in telomere length in humans shows signs of heritability and is maintained through life. Ann. NY Acad. Sci., 2006, 1067, 311-6.
23. Elenbaas, B.; Spirio, L.; Koerner, F.; Fleming, M.D.; Zimonjic, D.B.; Donaher, J.L.; Popescu, N.C.; Hahn, W.C.; Weinberg, R.A. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev., 2001, 15, 50-65.
24. Kim, N.W.; Piatyszek, M.A.; Prowse, K.R.; Harley, C.B.; West, M.D.; Ho, P.L.; Coviello, G.M.; Wright, W.E.; Weinrich, S.L.; Shay, J.W. Specific association of human telomerase activity with immortal cells and cancer. Science, 1994, 266, 2011-5.
25. Haugen, B.R.; Nawaz, S.; Markham, N.; Hashizumi, T.; Shroyer, A.L.; Werness, B.; Shroyer, K.R. Telomerase activity in benign and malignant thyroid tumors. Thyroid, 1997, 7, 337-342.
26. Yashima, K.; Vuitch, F.; Gazdar, A.F.; Fahey, T.J.III. Telomerase activity in benign and malignant thyroid diseases. Surgery, 1997, 122, 1141-1146.
27. Kammori, M.; Takubo, K.; Nakamura, K.I.; Furogouri, E.; Endo, H.; Kanauchi, H.; Mimura, Y.; Kaminishi, M. Telomerase activity and telomere length in benign and malignant human thyroid tissues. Cancer Lett., 2000, 159, 175-181.
28. Onoda, N.; Ishikawa, T.; Yoshikawa, K.; Sugano, S.; Kato, Y.; Sowa, M.; Hirakawa-Yong Suk Chung, K. Telomerase activity in thyroid tumors. Oncol. Rep., 1998, 5, 1447-1450.
29. Matthews, P.; Jones, C.J.; Skinner, J.; Haughton, M.; De Micco, C.; Wynford-Thomas, D. Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications. J. Pathol., 2001, 194, 183-193.
30. Aogi, K.; Kitahara, K.; Urquidi, V.; Tarin, D.; Goodison, S. comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid. Clin. Cancer Res., 1999, 5, 2790-2797.
31. Lo, C.Y.; Lam, K.Y.; Chan, K.T.; Luk, J.M. Telomerase activity in thyroid malignancy. Thyroid, 1999, 9, 1215-1220.
32. Umbricht, C.B.; Saji, M.; Westra, W.H.; Udelsman, R.; Zeiger, M.A.; Sukumar, S. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Res., 1997, 57, 2144-2147.
33. Brousset, P.; Chaouche, N.; Leprat, F.; Branet-Brousset, F.; Trouette, H.; Zenou, R.C.; Merlio, J.P.; Delsol, G. Telomerase activity in human thyroid carcinomas originating from the follicular cells. J. Clin. Endocrinol. Metab., 1997, 82, 4214-4216.
34. Hoang-Vu, C.; Boltze, C.; Gimm, O.; Poremba, C.; Dockhorndworniczak, B.; Kohrle, J.; Rath, F.W.; Dralle, H. Expression of telomerase genes in thyroid carcinoma. Int. J. Oncol., 2002, 21, 265-272.
35. Saji, M.; Xydas, S.; Westra, W.H.; Liang, C.K.; Clark, D.P.; Udelsman, R.; Umbricht, C.B.; Sukumar, S.; Zeiger, M.A. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms. Clin. Cancer Res., 1999, 5, 1483-1489.
36. Okayasu, I.; Osakabe, T.; Fujiwara, M.; Fukuda, H.; Kato, M.; Oshimura, M. Significant correlation of telomerase activity in thyroid papillary carcinomas with cell differentiation, proliferation and extrathyroidal extension. Jpn. J. Cancer Res., 1997 88, 965-70.
37. Bornstein-Quevedo, L.; Garcia-Hernandez, M.L.; Camacho-Arroyo, I.; Herrera, M.F.; Angeles, A.A.; Trevino, O.G.; Gamboa-Dominguez, A. Telomerase activity in well-differentiated papillary thyroid carcinoma correlates with advanced clinical stage of the disease. Endocr. Pathol., 2003, 14, 213-219.
38. Cheng, A.J.; Lin, J.D.; Chang, T.; Wang, T.CV. Telomerase activity in benign and malignant human thyroid tissues. Br. J. Cancer, 1998, 77, 2177-2180.
39. Zeiger, M.A.; Smallridge, R.C.; Clark, D.P.; Liang, C.K.; Carty, S.E.; Watson, C.G.; Udelsman, R.; Saji, M. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Surgery, 1999, 126, 1195-1199.
40. Ito, Y.; Yoshida, H.; Tomoda, C.; Uruno, T.; Takamura, Y.; Miya, A.; Kobayashi, K.; Matsuzuka, F.; Kuma, K.; Miyauchi, A. Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT). Anticancer Res., 2005, 25, 509-514.
41. Wang, S.L.; Chen, W.T.; Wu, M.T.; Chan, H.M.; Yang, S.F.; Chai, C.Y. Expression of human telomerase reverse transcriptase in thyroid follicular neoplasms: an immunohistochemical study. Endocr. Pathol., 2005, 16, 211-218.
42. Takano, T.; Ito, Y.; Matsuzuka, F.; Miya, A.; Kobayashi, K.; Yoshida, H.; Miyauchi, A. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines. Oncol. Rep., 2007, 18, 715-720.
43. Mitomo, S.; Maesawa, C.; Ogasawara, S.; Iwaya, T.; Shibazaki, M.; Yashima-Abo, A.; Kotani, K.; Oikawa, H.; Sakurai, E.; Izutsu, N.; Kato, K.; Komatsu, H.; Ikeda, K.; Wakabayashi, G.; Masuda, T. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci., 2008, 99, 280-6.
44. Straight, A.M.; Patel, A.; Fenton, C.; Dinauer, C.; Tuttle, R.M.; Francis, G.L. Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents. J. Endorinol. Invest., 2002, 25, 302-308.
45. Wang, Y.; Kowalski, J.; Tsai, H.L.; Marik, R.; Prasad, N.; Somervell, H.; Lo, P.K.; Sangenario, L. E.; Dyrskjot, L.; Orntoft, T.F.; Westra, W. H.; Meeker, A.K.; Eshelman, J.R.; Umbricht, C.B.; Zeiger, M.A. Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms. Thyroid, 2008, 18, 1055-1063.
46. Foukakis, T.; Gusnanto, A.; Au, A.Y.; Hoog, A.; Lui, W.O.; Larsson, C.; Wallin, G.; Zedenius, J. A PCR-based expression signature of malignancy in follicular thyroid tumors. Endocr. Relat. Cancer, 2007, 14, 381-391.
47. Svenson, U.; Roos, G. Telomere length as a biological marker in malignancy. Biochim Biophys Acta, 2009, 1792, 317-23.
48. Shen, J.; Terry, M.B.; Gurvich, I.; Liano, Y.; Senie, R.T.; Santella, R.M. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res., 2007, 67, 5538-44.
49. Broberg, K.; Bjork, J.; Paulsson, K.; Hoglund, M.; Albin, M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis, 2005, 26, 1263-1271.
50. Meeker, A.K.; Hicks, J.L.; Iacobuzio-Donahue, C.A.; Montgomery, E.A.; Westra, W.H.; Chan, T.Y.; Ronnett, B.M.; De Marzo, A.M. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin. Cancer Res., 2004, 10, 3317-26.
51. De Deken, X.; Vilain, C.; Van Sande, J.; Dumont, J.E.; Miot, F. decrease of telomere length in thyroid adenomas without telomerase activity. J. Clin. Endocrinol. Metab., 1998, 83, 4368-4372.
52. Achille, M.; Boukheris, H.; Caillou, B.; Talbot, M.; de Vathaire, F.; Sabatier, L.; Desmaze, C.; Schlumberger, M.; Soria, J.C. Expression of cell cycle biomarkers and telomere length in papillary thyroid carcinoma: a comparative study between radiation-associated and spontaneous cancers. Am. J. Clin. Oncol., 2009, 32, 1-8.
53. Aogi, K.; Kitahara, K.; Buley, I.; Backdahal, M.; Tahara, H.; Sugino, T.; Tarin, D.; Goodison, S. Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates. Clin. Cancer Res., 1998, 4, 1965-1970.
54. Sebesta, J.; Brown, T.; Williard, W.; Dehart, M.J.; Aldous, W.; Kavolius, J.; Azarow, K. Does telomerase add to the value of fine needle aspirations in evaluating thyroid nodules? Am. J. Surg., 2001, 181, 420-422.
55. Mora, J.; Lerma, E. Thyroid Neoplasia Study Group. Telomerase activity in thyroid fine needle apirates. Acta Cytol., 2004, 48, 818-824.
56. Lerma, E.; Mora, J. Telomerase activity in "suspicious" thyroid cytology. Cancer, 2005, 10, 492-497.
57. Kammori M.; Nakamura, K.; Hashimoto, M.; Ogawa, T.; Kaminishi, M.; Takubo, K. Clinical application of human telomeras riverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization. Int. J. Oncol., 2003, 22, 985-991.
58. Trulsson, L.M.; Velin, A.K.; Herder, A.; Söderkvist, P.; Rüter A.; Smeds, S. Telomerase activity in surgical specimens and fineneedle aspiration biopsies from hyperplastic and neoplastic human thyroid tissues. Am. J. Surg., 2003, 186, 83-8.
59. Siddiqui, M.T.; Greene, K.L.; Clark, D.P.; Xydas, S.; Udelsman, R.; Smallridge, R.C.; Zeiger, M.A.; Saji, M. Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules. Diagn. Mol. Pathol., 2001, 10, 123-9.
60. Liou, M.J.; Chan, E.C.; Lin, J.D.; Liu, F.H.; Chao, T.C. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Cancer Lett., 2003, 191, 223-7.
61. Guerra, L.N.; Miler, E.A.; Moiguer, S.; Karner, M.; Orlandi, A.M.; Fideleff, H.; Burdman, J.A. Telomerase activity in fine needle aspiration biopsy samples: application to diagnosis of human thyroid carcinoma. Clin. Chim. Acta, 2006, 370, 180-184.
62. Novakovic, S.; Hocevar, M.; Zgajnar, J.; Besic, N.; Stegel V. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer. Oncol. Rep., 2004, 11, 245-52.
63. Capezzone, M.; Cantara, S.; Marchisotta, S.; Filetti, S.; De Santi, M.M.; Rossi, B.; Ronga, G.; Durante, C.; Pacini, F. Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients. J. Clin. Endocrinol. Metab., 2008, 93, 3950-7.
64. Capezzone, M.; Marchisotta, S.; Cantara, S.; Busonero, G.; Brilli, L.; Pazaitou-Panayiotou, K.; Carli, A.F.; Caruso, G.; Toti, P.; Capitani, S.; Pammolli, A.; Pacini, F. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr. Relat. Cancer, 2008, 15, 1075-81.
65. McInnis, Mg. Anticipation: an old idea in new genes. Am. J. Hum. Genet., 1996, 59, 973-979.